The effective registration allows Yorkville to immediately sell shares, creating a persistent overhang. Traders should watch for any volume spikes or selling pressure, as the stock is likely to remain under pressure until the overhang clears or the company shows positive clinical catalysts.
Price Chart
Executive Summary
The SEC declared effective Jupiter Neurosciences' S-1 registration statement (File No. 333-297073), registering 16,000,000 shares for resale by Yorkville under a standby equity purchase agreement. This enables immediate dilution from Yorkville's potential selling, adding to the company's distressed capital structure with a going concern warning and $2.8M in outstanding convertible notes.
Key Facts
- S-1 registration declared effective on 2026-07-07, covering 16,000,000 shares for resale by Yorkville.
- Company is a clinical-stage biotech with a going concern warning and $2.8M in outstanding convertible notes to Yorkville.
- Market cap is approximately $10M, making the potential dilution from 16M shares significant.
Financial Impact
Potential dilution of up to 16M shares (likely >100% of current float) could depress the stock price, especially given the distressed capital structure and Yorkville's ability to sell into the market.
Risk Factors
- Imminent dilution from Yorkville's share resales, potentially driving the stock lower.
- Going concern risk and limited cash runway (no cash balance disclosed, but ongoing losses).
- Outstanding convertible notes could further dilute or force unfavorable financing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002213 |
| Document: 9999999995-26-002213-index.html | 9999999995-26-002213 |
| Document: 9999999995-26-002213.txt | 9999999995-26-002213 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 24, 2026 4w ago | S-3 | $2.67 $2.55 | ▲ +4.49% | ▲ +4.27% | $2.86 (−7.12%) |
Sep 22, 2026 4w ago | SC 13G | $2.98 $2.58 | ▼ −13.42% | ▼ −12.24% | $2.86 (−4.03%) |
Aug 28, 2026 8w ago | 8-K | $3.54 $3.08 | ▲ +12.99% | ▲ +12.85% | $2.86 (+19.21%) |
Aug 27, 2026 8w ago | 8-K | $4.89 $3.26 | ▲ +33.33% | ▲ +33.60% | $2.86 (+41.51%) |
Aug 24, 2026 8w ago | 8-K | $5.17 $3.35 | ▲ +35.20% | ▲ +34.66% | $2.86 (+44.68%) |
Aug 24, 2026 9w ago | 8-K | $5.66 $3.54 | ▲ +37.46% | ▲ +37.92% | $2.86 (+49.47%) |
Aug 24, 2026 9w ago | 424B5 | $5.66 $3.54 | ▲ +37.46% | ▲ +37.92% | $2.86 (+49.47%) |
Jul 27, 2026 13w ago | 8-K | $0.1135 $0.1000 | ▲ +11.89% | ▲ +14.41% | $2.86 (−2419.82%) |
Jul 21, 2026 13w ago | Press Release | $0.1697 $0.1097 | ▼ −35.36% | ▼ −34.36% | $2.86 (+1585.33%) |
Jul 8, 2026 15w ago | EFFECT | $0.1928 $0.1785 | ▲ +7.42% | ▲ +8.68% | $2.86 (−1383.40%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers